Insider Cluster (2 insiders) ·Filed May 19, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $560K total
Actionable Insight • Neutral

The cluster is too small to drive a directional trade. Monitor for any Form 4 filings by CEO/CFO in the next 30 days — if they also sell, that would be a more credible bearish signal. The offering extended cash runway into H1 2028, reducing near-term financing risk.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +19.32% at T+60d
NEUTRAL call ✓ call won +19.32% · α vs SPY +14.32% · entry $29.45 → $35.14
Entry anchored
May 19, 2026
via day open
T+1d
+3.70%
call +3.70% · α +3.51%
$30.54
settled 5mo ago
T+5d
+1.39%
call +1.39% · α -0.41%
$29.86
settled 4mo ago
T+20d
+11.38%
call +11.38% · α +10.63%
$32.80
settled 4mo ago
T+60d
+19.32%
call +19.32% · α +14.32%
$35.14
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Pharvaris sold a combined $560K in open-market sales on May 15, 2026, just 11 days after the company completed a ~$107.5M public offering at $29.68 per share. The sales are small relative to the $2.0B market cap (0.03%) and likely reflect post-offering liquidity/vesting rather than a bearish signal, but the proximity to the dilutive raise warrants attention.

Key Financial Metrics

Direction
selling
Total Value
$560.0K
Insiders
2

Key Facts

  • Chief Commercial Officer Wim Souverijns sold 10,000 shares at $29.92 for $299K on May 15, 2026.
  • Chief Technical Ops Officer Stefan Andreas Abele sold 8,748 shares at $29.82 for $261K on May 15, 2026.
  • Total insider sales of $560K represent 0.03% of Pharvaris's $2.0B market cap.
  • Sales occurred 11 days after a $107.5M public offering at $29.68 per share (424B5 filed May 8, 2026).
  • Both insiders sold on the same day, suggesting a shared liquidity event (e.g., post-offering blackout window opening) rather than coordinated bearish conviction.
  • Prior 30-day insider activity showed 4 sells totaling $1.4M, consistent with routine post-IPO/offering patterns.

Financial Impact

Total insider sales of $560K — trivial relative to $2.0B market cap and $107.5M offering proceeds.

dilution

Risk Factors

  • Further insider selling by C-suite could signal lack of confidence in near-term catalysts.
  • Post-offering dilution of ~3.9M shares may pressure stock in the short term.
  • Clinical-stage biotech binary risk: any pipeline setback could amplify insider selling patterns.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1779230721685
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 19, 2026